Annual Long Term Debt
$101.04 M
+$7.20 M+7.67%
31 December 2023
Summary:
BioXcel Therapeutics annual long term debt is currently $101.04 million, with the most recent change of +$7.20 million (+7.67%) on 31 December 2023. During the last 3 years, it has risen by +$99.64 million (+7127.32%). BTAI annual long term debt is now at all-time high.BTAI Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$104.60 M
+$1.34 M+1.30%
30 September 2024
Summary:
BioXcel Therapeutics quarterly long term debt is currently $104.60 million, with the most recent change of +$1.34 million (+1.30%) on 30 September 2024. Over the past year, it has increased by +$4.98 million (+5.00%). BTAI quarterly long term debt is now at all-time high.BTAI Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.7% | +5.0% |
| 3 y3 years | +7127.3% | +8764.5% |
| 5 y5 years | +100.0% | +9666.7% |
BTAI Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +9043.7% | at high | >+9999.0% |
| 5 y | 5 years | at high | at high | >+9999.0% | |
| alltime | all time | at high | at high |
BioXcel Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $104.60 M(+1.3%) |
| June 2024 | - | $103.26 M(+1.3%) |
| Mar 2024 | - | $101.98 M(+0.9%) |
| Dec 2023 | $101.04 M(+7.7%) | $101.04 M(+1.4%) |
| Sept 2023 | - | $99.62 M(+2.2%) |
| June 2023 | - | $97.46 M(+1.8%) |
| Mar 2023 | - | $95.77 M(+2.1%) |
| Dec 2022 | $93.84 M(+8392.0%) | $93.84 M(+1.4%) |
| Sept 2022 | - | $92.56 M(+49.2%) |
| June 2022 | - | $62.02 M(+5933.5%) |
| Mar 2022 | - | $1.03 M(-7.0%) |
| Dec 2021 | $1.10 M | $1.10 M(-6.4%) |
| Sept 2021 | - | $1.18 M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $1.25 M(-5.5%) |
| Mar 2021 | - | $1.33 M(-5.0%) |
| Dec 2020 | $1.40 M(+35.9%) | $1.40 M(-4.7%) |
| Sept 2020 | - | $1.47 M(+61.7%) |
| June 2020 | - | $907.00 K(-5.6%) |
| Mar 2020 | - | $961.00 K(-6.6%) |
| Dec 2019 | $1.03 M(>+9900.0%) | $1.03 M(-3.9%) |
| Sept 2019 | - | $1.07 M(-3.7%) |
| June 2019 | - | $1.11 M(-3.6%) |
| Mar 2019 | - | $1.15 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00 |
| July 2016 | $11.70 K(-99.1%) | - |
| July 2015 | $1.26 M(+553.1%) | - |
| July 2014 | $193.40 K | - |
FAQ
- What is BioXcel Therapeutics annual long term debt?
- What is the all time high annual long term debt for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual long term debt year-on-year change?
- What is BioXcel Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly long term debt year-on-year change?
What is BioXcel Therapeutics annual long term debt?
The current annual long term debt of BTAI is $101.04 M
What is the all time high annual long term debt for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual long term debt is $101.04 M
What is BioXcel Therapeutics annual long term debt year-on-year change?
Over the past year, BTAI annual long term debt has changed by +$7.20 M (+7.67%)
What is BioXcel Therapeutics quarterly long term debt?
The current quarterly long term debt of BTAI is $104.60 M
What is the all time high quarterly long term debt for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly long term debt is $104.60 M
What is BioXcel Therapeutics quarterly long term debt year-on-year change?
Over the past year, BTAI quarterly long term debt has changed by +$4.98 M (+5.00%)